==Tenet Healthcare (THC) reported earnings on Tue 30 Apr 24 (b/o)

 

Tenet Healthcare beats by $1.77, beats on revs; guides Q2 EPS above consensus, revs in-line; guides FY24 EPS above consensus, revs in-line

• Reports Q1 (Mar) earnings of $3.22 per share, excluding non-recurring items, $1.77 better than the FactSet Consensus of $1.45; revenues rose 6.9% year/year to $5.37 bln vs the $5.15 bln FactSet Consensus.
• Co issues guidance for Q2, sees EPS of $1.58-$1.98, excluding non-recurring items, vs. $1.46 FactSet Consensus; sees Q2 revs of $4.90-$5.1 bln vs. $4.94 bln FactSet Consensus.
• Co issues guidance for FY24, sees EPS of $8.37-$9.41, excluding non-recurring items, vs. $6.25 FactSet Consensus; sees FY24 revs of $20.0-$20.4 bln vs. $20.27 bln FactSet Consensus.

Earnings this week : Apr 29 - May 3, 24 (wk 18)

Monday (Apr 29)

• Morning:  BEN DPZ HNI HOPE JKS ON PHG RIG RVTY SOFI
• Afternoon:  ACGL AIN AKR AMKR BRX CCK CHGG CNO COUR CVI CWK EG ESI FFIV FLS HLIT KFRC LSCC LTC MED MSA MSTR NXPI PARA PCH PLOW QGEN RMBS SANM SBAC ST SUI WELL WWD YUMC

Tuesday (Apr 30)

• Morning:  ACIW ADM AEP AMT APD ARCB ATI AWI CNP CVLT DAN DEA DTM EAT ECL EPD ETN ETRN FELE FSS GEHC GLW GPK HEES HRMY HUBB INCY IPGP IT ITW KBR KO LDOS LEA LGIH LLY MAC MASS MCD MLCO MLM MMM MPC MPLX NOG OCSL OMF PAG PCAR PEG PNM PYPL SCL SIRI SITC SYY TAP THC THRM TKR TMHC  TREE  TRS TT UFPI ZBRA
• Afternoon:  AMD AMZN AROC ASH ATEN AX BLKB BXP CACC CC CCCS CHK CLX CZR DBRG DENN EIX EQH ESS EXEL EXR FANG FBIN GPOR HI HURN INVH KAI LC LEG LFUS LMND LPLA LUMN MATX MDLZ MIR MMSI NARI NEO NMIH OI OKE PDM PINS PK POWL PRU PSA RNR  ROOT RSG SBUX SILK SKT SMCI SON STAG SWKS SYK TMDX TXG UDR UMBF UNM VNOM VOYA WERN WPC WTTR ZYXI

Wednesday (May 1)

• Morning:  ADP AER ALKS APA ARCC ASTE AVA AVT AXTA BIP BLCO BRY CDW CG CHEF CLH CNDT COCO COR CRS CTS CVS DAY DD DFIN DRS EEFT EL ENTG ESAB EXTR GNRC GPN GRMN GSK GTES IDXX JCI KHC KKR LIVN LTH MA MAR NBIX NCLH NNN NSP OGE PFE PPL PSN PUMP RGEN ROCK SHOO SITE SLGN SMG SR STGW SXC TECH TRN TTMI UTHR VRSK WEC WING WLK YUM
• Afternoon:  ACHC ACLS AEIS AFG AFL AIG ALB ALKT ALL ANSS ATRC AWK AXS BALY BHE BV BZH CAR CCRN CDE CF CHRW CODI CORT CRK CSGS CTSH CTVA CVNA CW CWAN CWH DASH DGII DLX DVN EBAY ELME ENVX EPR EQC ERII ETSY EVTC EXPI FCPT FLEX FORM FRSH FSLR FSLY GKOS GRBK HCC HLF HPP HST HTLF INFA JAZZ KAR KLIC KMPR KN MAA MCW MET MGM MKL MOS MPWR MRO MTG MTRN MUSA MYRG NFG NGVT NOVA NSA NTGR NVST PAYC PCOR PGRE PPC PRCT PRDO PTC PTEN QCOM QRVO QTWO RDN RELY RHP RLJ RSI RYN SDGR SFM SIGI SKWD SRI SRPT SUM TENB THG TROX TSLX TTEK UGI UPWK VICI VMI VTR WHD WOLF ZG

Thursday (May 2)

• Morning: AGCO AGIO ALNY AME APG APO APPN APTV ARES ARW ATUS AUPH AVNS BAX BDC BDX BPMC BRKR BTSG BTU BWA CAH CGNX CHD CI CMI CNHI CNK COP CRTO CYBR D DNB DRVN ECVT ENOV ES EXC EXLS FDP FLWS FTDR GEL GERN HAYW HII HWM ICE IDA IDCC INMD IQV IRM ITRI ITT JHG K KIM KRP KTB KYMR LAMR LANC LIN LNC LNTH LXP MBUU MCO MDU MGPI MRNA MT MTSI MUR NSIT NVCR NVRI OGN OLPX OMCL PATK PBF PBI PENN PH PJT PNW PTON PWR REGN RXO SABR SEE SHAK SHC SNDR SO SSTK SWI SWK SWTX TFX THRY TPB ULCC UPBD UTZ VMC VNT W WCC WD WEN WRK XPEL XRAY XYL ZBH ZTS
• Afternoon:  AAON AAPL ACA ACCO AEE AES ALHC ALTR AMGN AMH ARDX ASUR ATGE BBAI BECN BFAM BILL BJRI BKNG CABO CIVI CLFD COHU COIN CPT CTOS CTRA DKNG DLB DLR DRH DVA ED EOG EXPE FIVN FND FOXF FRT FTNT GDDY GDYN HOLX HTGC HUN ICFI ILMN IR IRTC JRVR KRC KURA KWR LASR LMAT LNT LOCO LYV MODV MP MSI MTZ NET OEC OHI OLED OPEN PCTY PLMR POST PTVE PXD REG REZI RGA RKT RMAX RYAN SEM SIMO SM SPT SPXC SQ STEM SWN TNDM TRUP TWST TXRH UDMY VIAV VIR VREX VRRM WK WSC WTRG WW X XHR XPOF

Friday (May 3)  

• Morning:  ADNT ATMU AXL BCPC CBOE CBRE CRBG ESNT FLGT FLR FYBR GPRE GTLS HSY KOP LNG NMRK NVT OMI PAA PRLB TILE TNC TRMB UNIT XPO

 

==Tenet Healthcare (THC) reported earnings on Thur 20 Oct 22 (a/h)

 

Tenet Healthcare beats by $0.22, reports revs in-line; guides Q4 EPS below consensus, revs below consensus; also authorizes a $1 bln share repurchase program

• Reports Q3 (Sep) earnings of $1.44 per share, excluding non-recurring items, $0.22 better than the S&P Capital IQ Consensus of $1.22; revenues fell 1.9% year/year to $4.8 bln vs the $4.8 bln S&P Capital IQ Consensus.
• Co issues downside guidance for Q4, sees EPS of $1.00-1.54, excluding non-recurring items, vs. $1.77 S&P Capital IQ Consensus; sees Q4 revs of $4.816-$5.016 bln vs. $5.04 bln S&P Capital IQ Consensus.
• Co also authorizes a $1 bln share repurchase program.

=Tenet Healthcare (THC) reported earnings on Mon 25 Feb 19 (a/h)

Tenet Healthcare beats by $0.22, beats on revs; guides Q1 EPS below consensus, revs in-line; guides FY19 above consensus 

• Reports Q4 (Dec) earnings of $0.51 per share, excluding non-recurring items, $0.22 better than the S&P Capital IQ Consensus of $0.29; revenues fell 7.2% year/year to $4.62 bln vs the $4.5 bln S&P Capital IQ Consensus; same-facility system-wide revenue grew 3.8 percent, with cases up 0.9 percent and revenue per case up 2.8 percent.
• Co issues guidance for Q1, sees EPS of $0.10-0.43, excluding non-recurring items, vs. $0.46 S&P Capital IQ Consensus; sees Q1 revs of $4.3-4.6 bln vs. $4.57 bln S&P Capital IQ Consensus.
• Co issues upside guidance for FY19, sees EPS of $2.08-2.59, excluding non-recurring items, vs. $1.94 S&P Capital IQ Consensus; sees FY19 revs of $18.0-18.4 bln vs. $18.07 bln S&P Capital IQ Consensus.

Earnings this week : Feb. 25 - March 1, 2019 (wk 9)

Earnings confirmed to report this week:

Monday (Feb 25)

• Morning: PLAN AWI CRI DORM KOS MDR TEN
• Afternoon:  ALSN APLE APTS ATH AWR BWXT CDEV CORT CRZO DDS  DRH ELGX EPR ETSY EVER FBM FRAC FRGI GSM HNI HTZ IMMU JBT KAMN KBR LDL LSI MEDP MOS NGHC NLS OFIX OKE PBPB PEB PLOW PODD QTS RCII RP RRC SHAK SNHY SYKE THC TRTX TWOU XENT

Tuesday (Feb 26)

• Morning:  AMWD ATHM AVNS AZO BCC BLD BMO BNS BPMC CBRL CLVS DISCA DSX FCN HD LGIH LNG M MNK NCI NXST PRFT RHP RLGY SAFM SDRL SERV SFL SJM SPNS SRE SSTK TA TLRA TPH TREE TRI TRXC USCR VCEL VSI WP WYND XHR
• Afternoon:  AAXN ACAD AKCA ARNA AXGN BGS BNFT CERS CGBD CIR CLGX CPE CSGP CW DRQ DVAX ELF ENPH EOG EVH FOXF FRPT FTR GWPH HEI HPR HURN HY ICFI IMAX IMMR INGN INN INSP JAZZ JBGS MASI MED MELI MGRC MMSI MTDR MYL NBR OAS ORA OUT PANW PEN PLNT PSA PUMP PZZA RRD RRGB RTRX SE SUPN SYX TIVO TNDM TOL VEEV WLL WMGI WTTR WTW

Wednesday (Feb 27)

• Morning:  AES AMRN AMT ANIP BBY CHK CLH CPB DF DNR DOC DY EYE FTDR GCP GTE HMLP HPT HZNP IONS LIVN LOW LXP MDCO MGPI MIDD NEWM NOVT OCN ODP PEG PGTI PNM RDC SBGI SHOO TAST TJX UTHR WAAS 
• Afternoon:  AEGN ALEX AMED ANSS APA ATSG AYX BEL BGNE BILI BKNG BOLD BOX CABO CCRN CHDN COLL CRC CVNA CWK DAR ECPG ERI ESTC ESV FG FIT FOE FTAI FTSI GEF GKOS HGV HHC HPQ ITRI KRA KW LADR LB LHCG MNST NNI ORBC PDCE PK PRAH PRGO PRSC QRTE.A SEMG SJI SOI SQ SRI SRPT STAY SWX TDOC TPC TROX TWNK UHS WIFI WING WTI XLRN

Thursday (Feb 28)

• Morning: AAON ABB ACIW AKRX AMCX AMRX BCPC BID BMCH BPMP BUD CARS CM CMD CNP CRAI CROX CWEN CWT DAVA DEA EGRX ENDP EXLS FOLD FRO FSS GOLF GTN GTS GTT HMHC HRI IBP ICPT IRDM JCP JD KDP LAUR LKQ MGLN MYE NLSN NOMD NRG OPI OXSQ PCRX PDCO PRIM PRTY SEAS SPAR STWD SYNH TD TRS TTI VAC VRTV VST
• Afternoon:  DDD ACHC AIMT ALRM AQN ALTR AMBC AMC APPF AGO ATRC ADSK EQH BIO BLDR CARG CSLT CISN SCOR DELL DCO EIX EDIT FTCH FNKO GCAP GPS GSBD HABT ICUI XON JAG KTOS LYV MAIN MAR MTZ MAXR MBI NKTR NPTN JWN NTNX PLYA PRAA PTCT PBYI PSTG KWR RDUS RBA RLJ SGMO SRG SWN SPPI SPLK SRCL RUN TRHC TCMD TERP TPIC UPWK VMW WDAY ZIXI ZGNX ZS WUBA 

Friday (March 1)

• Morning:  ASTE CLNY CORE XRAY EBIX FL KOP NWN PEGI PTLA SSP SNH STRA TGNA TRCO 

******

• Monday: December Wholesale Inventories (Briefing.com consensus 0.4%; prior 0.3%) at 10:00 ET; $40 bln 2-yr Treasury note auction results at 11:30 ET; and $41 bln 5-yr Treasury note auction results at 13:00 ET
• Tuesday: December S&P Case-Shiller Home Price Index (Briefing.com consensus 4.5%; prior 4.7%) at 8:00 ET; December Housing Starts (Briefing.com consensus 1254K; prior 1256K) and Building Permits (Briefing.com consensus 1290K; prior 1328K) at 8:30 ET; December FHFA Housing Price Index (prior 0.4%) at 9:00 ET; February Consumer Confidence (Briefing.com consensus 125.0; prior 120.2) at 10:00 ET; and $32 bln 7-yr Treasury note auction results at 13:00 ET
• Wednesday: Weekly MBA Mortgage Index (prior 3.6%) at 7:00 ET; January Advance Intl. Trade in Goods; Advance Retail Inventories; and Advance Wholesale Inventories at 8:30 ET; December Factory Orders (Briefing.com consensus 1.0%; prior -0.6%), Fed Chair Powell Semi-Annual Monetary Policy Testimony, and January Pending Home Sales (Briefing.com consensus -0.4%; prior -2.2%) at 10:00 ET; and Weekly EIA Crude Oil Inventories (prior +3.7M) at 10:30 ET
• Thursday: Q4 GDP - Advance (Briefing.com consensus 2.3%; prior 3.4%), Q4 GDP Deflator - Advance (Briefing.com consensus 1.7%; prior 1.8%), weekly Initial Claims (Briefing.com consensus 221K; prior 216K), and Continuing Claims (prior 1725K) at 8:30 ET; February Chicago PMI (Briefing.com consensus 57.5; prior 56.7) at 9:45 ET; and weekly EIA Natural Gas Inventories (prior -177 bcf) at 10:30 ET
• Friday: December Personal Income (Briefing.com consensus 0.3%; prior 0.2%), Personal Spending (Briefing.com consensus -0.2%; prior 0.4%), and January Personal Income (Briefing.com consensus 0.3%) at 8:30 ET; February ISM Manufacturing Index (Briefing.com consensus 56.0; prior 56.6), and Final February Michigan Consumer Sentiment (Briefing.com consensus 95.6; prior 95.5) at 10:00 ET

-=Tenet Healthcare (THC) reported earnings on Tue 1 May 2018 (b/o)

Tenet Healthcare beats by $0.61, beats on revs; guides Q2 EPS in-line, revs in-line; guides FY18 EPS above consensus, revs in-line 

• Reports Q1 (Mar) earnings of $0.57 per share, excluding non-recurring items, $0.61 better than the Capital IQ Consensus of ($0.04); revenues fell 2.4% year/year to $4.7 bln vs the $4.56 bln Capital IQ Consensus.
• Co issues in-line guidancefor Q2, sees EPS of $0.15-0.29, excluding non-recurring items, vs. $0.17 Capital IQ Consensus Estimate; sees Q2 revs of $4.475-4.675 bln vs. $4.5 bln Capital IQ Consensus Estimate.
• Co issues guidancefor FY18, sees EPS of $1.36-1.70, excluding non-recurring items, vs. $0.92 Capital IQ Consensus Estimate; sees FY18 revs of $17.9-18.3 bln vs. $18.06 bln Capital IQ Consensus Estimate.

-=Tenet Healthcare (THC) reported earnings on Mon 26 Feb 2018 (a/h)

Tenet Healthcare beats by $0.12, beats on revs; guides Q1 EPS mostly below consensus, revs below consensus; guides FY18 EPS in-line, revs in-line

• Reports Q4 (Dec) earnings of $1.40 per share, excluding non-recurring items, $0.12 better thanthe Capital IQ Consensus of $1.28 and company guidance of $1.20-$1.35; revenues rose 2.4% year/year to $4.98 bln vs the $4.85 bln Capital IQ Consensus.
• "Our results for the fourth quarter were strong in each of our business segments," said Ronald A. Rittenmeyer, executive chairman and CEO. "Volume growth returned in our hospital and Ambulatory segments, cost controls were tight, and our financial results at USPI and Conifer were very strong. Our cost control program is off to a great start and, when combined with improved financial performance in the fourth quarter, we are raising our Outlook for Adjusted EBITDA and Adjusted EPS for 2018."
• Co issues guidance for Q1, sees EPS of ($0.10)-$0.05, excluding non-recurring items, vs. $0.05 Capital IQ Consensus Estimate; sees Q1 revs of $4.45-$4.65 bln vs. $4.66 bln Capital IQ Consensus Estimate.
• Co issues in-line guidancefor FY18, sees EPS of $0.73-$1.07, excluding non-recurring items, vs. $0.78 Capital IQ Consensus Estimate and up from January pre-announcement of $0.58-$0.97; sees FY18 revs of $17.9-$18.3 bln vs. $18.26 bln Capital IQ Consensus Estimate. Adjusted EBITDA expected to be $2.50-$2.60 bln, up $25 mln at the midpoint from prior guidance

=Tenet Healthcare (THC) reported earnings on Mon 27 Feb 17 (a/h)

Tenet Healthcare misses by $0.16, misses on revs; guides Q1 revs in-line and EPS below consensus; guides FY17 EPS below consensus, revs in-line:

• Reports Q4 (Dec) earnings of $0.06 per share, excluding non-recurring items, $0.16 worse than the Capital IQ Consensus of $0.22; revenues fell 3.3% year/year to $4.86 bln vs the $4.95 bln Capital IQ Consensus.
  • Same-hospital patient revenue grew 3.2% in the fourth quarter and reflects a 3.7% increase in revenue per adjusted admission partially offset by a 0.5% decline in adjusted admissions.
  • Ambulatory Care segment revenue increased 5.9% on a same-facility system-wide basis in the fourth quarter, with cases increasing 1.7% and revenue per case increasing 4.1%.
  • Revenue from Conifer Health Solutions increased 4.7% in the fourth quarter with revenue from third parties increasing 16.0%.
• Trevor Fetter, chairman and chief executive officer, stated, "Demand for higher acuity services in our hospitals drove growth in same-hospital patient revenue and revenue per adjusted admission in the fourth quarter. Our Ambulatory and Conifer Health businesses delivered strong revenue and Adjusted EBITDA growth. Our expectations for continued growth in 2017 reflect confidence in our strategy to strengthen our hospital portfolio, expand our network of ambulatory facilities, and solidify Conifer's leadership in healthcare business services." 
• Co issues in-line guidance for Q1, sees Q1 revs of $4.75-4.95 bln vs. $4.9 bln Capital IQ Consensus Estimate.  Adjusted diluted EPS (loss) from continuing operations to be between ($0.60) and ($0.45), which is below the S&P Capital IQ consensus estimate of $0.43
• Co issues guidance for FY17, sees EPS of $1.05-1.30, excluding non-recurring items, vs. $1.96 Capital IQ Consensus Estimate; sees FY17 revs of $19.7-20.1 bln vs. $20 bln Capital IQ Consensus Estimate.
  • The Outlook for 2017 assumes equity in earnings of unconsolidated affiliates of $145 million to $155 million, electronic health record incentives of $8 million to $10 million, net income attributable to noncontrolling interests of $390 million to $410 million and an average diluted share count of 102 million. In addition, the Outlook assumes that CMS will approve the proposed California Provider Fee for the 30-month period from January 2017 through June 2019 during the fourth quarter of 2017 and further assumes that the Company will record approximately $220 million to $230 million of revenue and Adjusted EBITDA during 2017 as a result of this program.